The effect of sodium glucose Co-transport 2 inhibitors on cognitive impairment and depression in type 2 diabetes mellitus patients

• Päätekijät: Ashurova Nodirahon (Tekijä), Haya Majid (Tekijä), Swati Waghdhare (Tekijä), Divya Vohora (Tekijä), Nidhi (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background and aim: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder often associated with thyroid dysfunction. Sodium-glucose co-transport 2 (SGLT2) inhibitors, a novel class of medications for T2DM, have shown potential effects on various physiological systems, including the centr...